Concepts (334)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Photoperiod | 56 | 2022 | 73 | 12.450 |
Why?
|
| Circadian Rhythm | 28 | 2022 | 304 | 7.110 |
Why?
|
| Phodopus | 54 | 2019 | 59 | 6.550 |
Why?
|
| Seasons | 27 | 2019 | 239 | 4.740 |
Why?
|
| Cricetinae | 58 | 2019 | 558 | 4.590 |
Why?
|
| Motor Activity | 22 | 2016 | 327 | 3.080 |
Why?
|
| Melatonin | 17 | 2013 | 50 | 2.630 |
Why?
|
| Activity Cycles | 8 | 2022 | 19 | 2.600 |
Why?
|
| Reproduction | 18 | 2019 | 199 | 2.570 |
Why?
|
| Behavior, Animal | 15 | 2023 | 378 | 2.460 |
Why?
|
| Hypothalamus | 11 | 2019 | 79 | 2.390 |
Why?
|
| Sex Characteristics | 9 | 2023 | 327 | 2.220 |
Why?
|
| Testis | 24 | 2014 | 152 | 2.060 |
Why?
|
| Immune System | 9 | 2020 | 97 | 1.980 |
Why?
|
| Animals | 86 | 2023 | 27481 | 1.680 |
Why?
|
| Circadian Clocks | 4 | 2021 | 63 | 1.630 |
Why?
|
| Iodide Peroxidase | 5 | 2013 | 206 | 1.620 |
Why?
|
| Leukocytes | 7 | 2013 | 208 | 1.490 |
Why?
|
| Testosterone | 8 | 2014 | 272 | 1.470 |
Why?
|
| Ultradian Rhythm | 2 | 2022 | 4 | 1.400 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2023 | 201 | 1.310 |
Why?
|
| Lipopolysaccharides | 12 | 2019 | 294 | 1.310 |
Why?
|
| Body Weight | 23 | 2023 | 453 | 1.300 |
Why?
|
| Depression | 5 | 2014 | 512 | 1.270 |
Why?
|
| Pineal Gland | 7 | 2013 | 15 | 1.260 |
Why?
|
| Light | 13 | 2022 | 292 | 1.240 |
Why?
|
| Cytokines | 8 | 2019 | 806 | 1.140 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 2014 | 127 | 1.130 |
Why?
|
| Adaptation, Physiological | 6 | 2019 | 314 | 1.090 |
Why?
|
| Endotoxins | 3 | 2014 | 36 | 1.070 |
Why?
|
| Immunity | 3 | 2020 | 141 | 1.060 |
Why?
|
| Male | 64 | 2023 | 42488 | 1.020 |
Why?
|
| Sexual Maturation | 3 | 2018 | 35 | 1.010 |
Why?
|
| Eating | 10 | 2019 | 167 | 0.950 |
Why?
|
| Pharmacokinetics | 2 | 2023 | 10 | 0.930 |
Why?
|
| Period Circadian Proteins | 2 | 2021 | 10 | 0.910 |
Why?
|
| Research Personnel | 1 | 2024 | 72 | 0.900 |
Why?
|
| Inflammation | 3 | 2015 | 975 | 0.870 |
Why?
|
| Suprachiasmatic Nucleus | 3 | 2013 | 6 | 0.830 |
Why?
|
| Illness Behavior | 4 | 2019 | 7 | 0.820 |
Why?
|
| Triiodothyronine | 4 | 2019 | 345 | 0.820 |
Why?
|
| Darkness | 7 | 2022 | 49 | 0.810 |
Why?
|
| Rats, Wistar | 7 | 2014 | 303 | 0.790 |
Why?
|
| Female | 42 | 2023 | 46401 | 0.730 |
Why?
|
| Body Temperature | 6 | 2017 | 125 | 0.710 |
Why?
|
| Periodicity | 5 | 2017 | 119 | 0.700 |
Why?
|
| Organ Size | 13 | 2013 | 370 | 0.690 |
Why?
|
| Interleukin-1beta | 5 | 2014 | 82 | 0.670 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 3 | 2016 | 16 | 0.670 |
Why?
|
| Olfactory Bulb | 2 | 2009 | 41 | 0.630 |
Why?
|
| Social Change | 1 | 2018 | 8 | 0.620 |
Why?
|
| Microbiota | 2 | 2022 | 406 | 0.580 |
Why?
|
| Corticosterone | 3 | 2012 | 35 | 0.580 |
Why?
|
| Social Behavior | 4 | 2018 | 299 | 0.570 |
Why?
|
| Feeding Behavior | 4 | 2014 | 327 | 0.570 |
Why?
|
| Wound Healing | 3 | 2016 | 360 | 0.560 |
Why?
|
| Hypothalamo-Hypophyseal System | 4 | 2011 | 81 | 0.540 |
Why?
|
| Emotions | 2 | 2013 | 352 | 0.540 |
Why?
|
| Immunity, Innate | 4 | 2019 | 433 | 0.540 |
Why?
|
| Mesocricetus | 3 | 2014 | 105 | 0.510 |
Why?
|
| Neuroimmunomodulation | 2 | 2007 | 11 | 0.500 |
Why?
|
| Social Environment | 4 | 2011 | 187 | 0.500 |
Why?
|
| Hypersensitivity, Delayed | 4 | 2013 | 25 | 0.500 |
Why?
|
| Time Factors | 11 | 2024 | 5337 | 0.500 |
Why?
|
| Sexual Behavior, Animal | 3 | 2014 | 95 | 0.490 |
Why?
|
| Rats | 9 | 2022 | 4041 | 0.490 |
Why?
|
| Skin Diseases | 1 | 2016 | 173 | 0.490 |
Why?
|
| RNA, Messenger | 5 | 2014 | 2021 | 0.480 |
Why?
|
| Immunologic Memory | 2 | 2008 | 163 | 0.480 |
Why?
|
| Biomedical Research | 2 | 2022 | 402 | 0.480 |
Why?
|
| Gonadal Hormones | 1 | 2014 | 2 | 0.470 |
Why?
|
| Endotoxemia | 1 | 2014 | 18 | 0.460 |
Why?
|
| Neuropeptides | 3 | 2019 | 115 | 0.450 |
Why?
|
| Time Perception | 1 | 2013 | 24 | 0.450 |
Why?
|
| Sodium Glutamate | 1 | 2013 | 2 | 0.440 |
Why?
|
| Analysis of Variance | 8 | 2013 | 899 | 0.440 |
Why?
|
| Thyroxine | 2 | 2013 | 354 | 0.430 |
Why?
|
| Neurosciences | 1 | 2014 | 52 | 0.430 |
Why?
|
| Frontal Lobe | 1 | 2014 | 132 | 0.430 |
Why?
|
| Dermatitis | 1 | 2013 | 34 | 0.420 |
Why?
|
| Hippocampus | 2 | 2014 | 449 | 0.420 |
Why?
|
| Pituitary-Adrenal System | 2 | 2011 | 64 | 0.420 |
Why?
|
| Nerve Net | 1 | 2016 | 374 | 0.420 |
Why?
|
| Locomotion | 4 | 2022 | 140 | 0.410 |
Why?
|
| Hydrocortisone | 6 | 2013 | 301 | 0.410 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 200 | 0.400 |
Why?
|
| Fever | 6 | 2015 | 127 | 0.400 |
Why?
|
| Gene Expression Regulation | 3 | 2013 | 1983 | 0.400 |
Why?
|
| Follicle Stimulating Hormone | 3 | 2008 | 147 | 0.390 |
Why?
|
| DNA Methylation | 2 | 2013 | 663 | 0.390 |
Why?
|
| Individuality | 1 | 2012 | 110 | 0.390 |
Why?
|
| Estradiol | 1 | 2012 | 250 | 0.390 |
Why?
|
| Disease Susceptibility | 1 | 2012 | 200 | 0.390 |
Why?
|
| Lymphocytes | 3 | 2003 | 468 | 0.380 |
Why?
|
| Vision, Monocular | 1 | 2011 | 15 | 0.380 |
Why?
|
| Vision, Binocular | 1 | 2011 | 21 | 0.370 |
Why?
|
| Ghrelin | 1 | 2010 | 29 | 0.360 |
Why?
|
| Receptor, Melatonin, MT1 | 1 | 2009 | 1 | 0.350 |
Why?
|
| Receptor, Melatonin, MT2 | 1 | 2009 | 2 | 0.350 |
Why?
|
| Bacterial Infections | 2 | 2010 | 184 | 0.340 |
Why?
|
| Aging | 2 | 2013 | 724 | 0.340 |
Why?
|
| Hemocyanins | 3 | 2004 | 7 | 0.340 |
Why?
|
| Anxiety | 2 | 2009 | 310 | 0.330 |
Why?
|
| Mice | 8 | 2023 | 11832 | 0.330 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 520 | 0.330 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2009 | 23 | 0.320 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2009 | 57 | 0.320 |
Why?
|
| Orchiectomy | 5 | 2014 | 62 | 0.320 |
Why?
|
| Dinitrofluorobenzene | 2 | 2009 | 3 | 0.310 |
Why?
|
| Body Temperature Regulation | 2 | 2022 | 56 | 0.300 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 1281 | 0.300 |
Why?
|
| Influenza, Human | 1 | 2011 | 340 | 0.300 |
Why?
|
| Cognition Disorders | 1 | 2010 | 234 | 0.300 |
Why?
|
| Nesting Behavior | 4 | 2008 | 20 | 0.290 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 289 | 0.290 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2007 | 131 | 0.290 |
Why?
|
| Behavioral Symptoms | 1 | 2007 | 15 | 0.290 |
Why?
|
| Virus Diseases | 1 | 2008 | 98 | 0.290 |
Why?
|
| Spleen | 5 | 2013 | 433 | 0.280 |
Why?
|
| Animals, Newborn | 3 | 2013 | 524 | 0.270 |
Why?
|
| Luteinizing Hormone | 1 | 2006 | 167 | 0.260 |
Why?
|
| Antioxidants | 1 | 2007 | 226 | 0.260 |
Why?
|
| Exploratory Behavior | 4 | 2013 | 48 | 0.260 |
Why?
|
| T-Lymphocytes | 3 | 2020 | 1221 | 0.260 |
Why?
|
| Neuroendocrinology | 1 | 2005 | 4 | 0.260 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2006 | 106 | 0.260 |
Why?
|
| Immune Tolerance | 1 | 2008 | 341 | 0.250 |
Why?
|
| Affect | 1 | 2007 | 389 | 0.240 |
Why?
|
| Food Deprivation | 3 | 2019 | 24 | 0.240 |
Why?
|
| Swimming | 3 | 2013 | 63 | 0.240 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 373 | 0.230 |
Why?
|
| Androgens | 1 | 2005 | 175 | 0.230 |
Why?
|
| Memory | 2 | 2010 | 220 | 0.220 |
Why?
|
| Sick Role | 3 | 2008 | 13 | 0.220 |
Why?
|
| Enzyme Induction | 2 | 2014 | 88 | 0.220 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 2 | 2014 | 56 | 0.220 |
Why?
|
| Pest Control | 1 | 2023 | 6 | 0.210 |
Why?
|
| Wavelet Analysis | 1 | 2022 | 2 | 0.210 |
Why?
|
| Hormones | 2 | 2014 | 139 | 0.210 |
Why?
|
| Sex Factors | 2 | 2023 | 1073 | 0.210 |
Why?
|
| Prealbumin | 1 | 2002 | 34 | 0.210 |
Why?
|
| Skin | 3 | 2005 | 589 | 0.210 |
Why?
|
| Thyroxine-Binding Proteins | 1 | 2002 | 86 | 0.210 |
Why?
|
| Leukocyte Count | 3 | 2009 | 223 | 0.210 |
Why?
|
| Hibernation | 1 | 2002 | 5 | 0.200 |
Why?
|
| Immunity, Cellular | 1 | 2003 | 178 | 0.200 |
Why?
|
| Breeding | 2 | 2018 | 41 | 0.200 |
Why?
|
| Signal Transduction | 4 | 2016 | 3397 | 0.200 |
Why?
|
| Biology | 1 | 2022 | 52 | 0.200 |
Why?
|
| Peromyscus | 1 | 2001 | 13 | 0.200 |
Why?
|
| Anorexia | 3 | 2019 | 28 | 0.200 |
Why?
|
| Neurosecretory Systems | 1 | 2001 | 36 | 0.190 |
Why?
|
| Rodentia | 1 | 2001 | 41 | 0.190 |
Why?
|
| Arousal | 1 | 2002 | 170 | 0.190 |
Why?
|
| Hypothyroidism | 1 | 2002 | 242 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 2 | 2003 | 511 | 0.180 |
Why?
|
| Age Factors | 4 | 2013 | 1877 | 0.180 |
Why?
|
| Cell Division | 4 | 2003 | 692 | 0.180 |
Why?
|
| Pregnancy | 4 | 2014 | 3038 | 0.180 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2020 | 23 | 0.180 |
Why?
|
| Mammals | 1 | 2022 | 237 | 0.180 |
Why?
|
| Castration | 2 | 2014 | 37 | 0.170 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2019 | 13 | 0.170 |
Why?
|
| Ovary | 2 | 2012 | 262 | 0.160 |
Why?
|
| Hair | 2 | 2013 | 56 | 0.160 |
Why?
|
| Immunohistochemistry | 3 | 2013 | 1798 | 0.160 |
Why?
|
| Chimera | 1 | 1998 | 56 | 0.160 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2019 | 51 | 0.160 |
Why?
|
| Cachexia | 2 | 2009 | 13 | 0.160 |
Why?
|
| Regression Analysis | 3 | 2012 | 590 | 0.150 |
Why?
|
| Humans | 9 | 2024 | 89613 | 0.150 |
Why?
|
| Weight Gain | 2 | 2019 | 119 | 0.150 |
Why?
|
| Energy Metabolism | 1 | 2019 | 280 | 0.140 |
Why?
|
| Gene Expression | 2 | 2013 | 1309 | 0.140 |
Why?
|
| Down-Regulation | 2 | 2019 | 520 | 0.140 |
Why?
|
| Dopaminergic Neurons | 1 | 2016 | 25 | 0.140 |
Why?
|
| Cues | 2 | 2009 | 174 | 0.130 |
Why?
|
| Radioimmunoassay | 3 | 2008 | 155 | 0.130 |
Why?
|
| Stress, Psychological | 2 | 2013 | 321 | 0.130 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 358 | 0.130 |
Why?
|
| Sleep | 1 | 2020 | 455 | 0.130 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 2384 | 0.130 |
Why?
|
| Lactation | 2 | 2012 | 54 | 0.120 |
Why?
|
| Dorsomedial Hypothalamic Nucleus | 1 | 2014 | 2 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 885 | 0.120 |
Why?
|
| Diet, High-Fat | 1 | 2015 | 119 | 0.120 |
Why?
|
| Aggression | 1 | 2018 | 322 | 0.120 |
Why?
|
| Dark Adaptation | 1 | 2013 | 12 | 0.110 |
Why?
|
| Dysbiosis | 1 | 2015 | 81 | 0.110 |
Why?
|
| CD11b Antigen | 1 | 2014 | 36 | 0.110 |
Why?
|
| RNA, Neoplasm | 1 | 2014 | 88 | 0.110 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 201 | 0.110 |
Why?
|
| DNA Restriction Enzymes | 1 | 2013 | 97 | 0.110 |
Why?
|
| Biological Clocks | 2 | 2006 | 74 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 2 | 2015 | 868 | 0.110 |
Why?
|
| Immunization | 2 | 2004 | 163 | 0.110 |
Why?
|
| Social Isolation | 1 | 2013 | 67 | 0.110 |
Why?
|
| Lighting | 1 | 2013 | 33 | 0.110 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 191 | 0.110 |
Why?
|
| Genitalia | 1 | 2013 | 21 | 0.110 |
Why?
|
| Lymphoid Tissue | 1 | 2013 | 57 | 0.110 |
Why?
|
| Weaning | 1 | 2013 | 25 | 0.110 |
Why?
|
| Seminal Vesicles | 1 | 2013 | 39 | 0.110 |
Why?
|
| Methylnitrosourea | 1 | 2012 | 7 | 0.110 |
Why?
|
| Homing Behavior | 1 | 2012 | 6 | 0.100 |
Why?
|
| Color | 1 | 2013 | 85 | 0.100 |
Why?
|
| Estrous Cycle | 1 | 2012 | 8 | 0.100 |
Why?
|
| Extremities | 1 | 2013 | 172 | 0.100 |
Why?
|
| Tumor Burden | 1 | 2014 | 305 | 0.100 |
Why?
|
| DNA, Complementary | 1 | 2013 | 391 | 0.100 |
Why?
|
| Pregnancy, Animal | 1 | 2012 | 58 | 0.100 |
Why?
|
| Hypothermia | 1 | 2011 | 26 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 282 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 217 | 0.100 |
Why?
|
| Cholera Toxin | 1 | 2011 | 21 | 0.100 |
Why?
|
| Vagina | 1 | 2013 | 177 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2013 | 689 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 919 | 0.090 |
Why?
|
| Orexins | 1 | 2010 | 8 | 0.090 |
Why?
|
| Neuropeptide Y | 1 | 2010 | 32 | 0.090 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2022 | 125 | 0.090 |
Why?
|
| Maze Learning | 1 | 2010 | 29 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2010 | 68 | 0.090 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2010 | 27 | 0.090 |
Why?
|
| 5-Methoxytryptamine | 1 | 2009 | 1 | 0.090 |
Why?
|
| Visual Acuity | 1 | 2011 | 199 | 0.090 |
Why?
|
| Indenes | 1 | 2009 | 9 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2011 | 312 | 0.090 |
Why?
|
| Telemetry | 1 | 2010 | 36 | 0.090 |
Why?
|
| Cerebrum | 1 | 2009 | 16 | 0.090 |
Why?
|
| Fear | 1 | 2010 | 79 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2013 | 451 | 0.080 |
Why?
|
| Gene Expression Profiling | 3 | 2019 | 1446 | 0.080 |
Why?
|
| Brain | 2 | 2013 | 2300 | 0.080 |
Why?
|
| Retina | 1 | 2011 | 220 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 182 | 0.080 |
Why?
|
| Anhedonia | 1 | 2009 | 12 | 0.080 |
Why?
|
| RNA | 1 | 2013 | 583 | 0.080 |
Why?
|
| Species Specificity | 2 | 2019 | 685 | 0.080 |
Why?
|
| Models, Statistical | 1 | 2012 | 575 | 0.080 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2008 | 42 | 0.080 |
Why?
|
| Saccharin | 1 | 2008 | 9 | 0.080 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2015 | 516 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 387 | 0.080 |
Why?
|
| Gram-Negative Bacteria | 1 | 2008 | 35 | 0.080 |
Why?
|
| Gram-Positive Bacteria | 1 | 2008 | 18 | 0.080 |
Why?
|
| Escape Reaction | 1 | 2007 | 12 | 0.080 |
Why?
|
| Drinking | 1 | 2007 | 33 | 0.070 |
Why?
|
| Solutions | 1 | 2007 | 86 | 0.070 |
Why?
|
| Osmolar Concentration | 1 | 2007 | 182 | 0.070 |
Why?
|
| Sunlight | 1 | 2007 | 28 | 0.070 |
Why?
|
| Sucrose | 1 | 2007 | 65 | 0.070 |
Why?
|
| Lymphocyte Subsets | 1 | 2007 | 66 | 0.070 |
Why?
|
| Phototherapy | 1 | 2007 | 35 | 0.070 |
Why?
|
| Phenotype | 1 | 2014 | 2449 | 0.070 |
Why?
|
| Biomimetics | 1 | 2007 | 31 | 0.070 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 188 | 0.070 |
Why?
|
| Learning | 1 | 2010 | 285 | 0.070 |
Why?
|
| Diet | 1 | 2009 | 443 | 0.070 |
Why?
|
| Biomarkers | 1 | 2012 | 1768 | 0.060 |
Why?
|
| Dinoprostone | 2 | 2003 | 70 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2007 | 466 | 0.060 |
Why?
|
| Adolescent | 1 | 2018 | 9305 | 0.060 |
Why?
|
| Climate | 1 | 2005 | 58 | 0.060 |
Why?
|
| Reflex, Startle | 1 | 2005 | 32 | 0.060 |
Why?
|
| Models, Biological | 1 | 2012 | 1762 | 0.060 |
Why?
|
| Behavior | 1 | 2005 | 85 | 0.060 |
Why?
|
| Social Facilitation | 1 | 2004 | 8 | 0.060 |
Why?
|
| Weight Loss | 1 | 2006 | 231 | 0.060 |
Why?
|
| Dinitrobenzenes | 1 | 2004 | 5 | 0.060 |
Why?
|
| Smell | 1 | 2005 | 112 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 36 | 0.060 |
Why?
|
| Immunoglobulins | 1 | 2004 | 143 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2003 | 163 | 0.050 |
Why?
|
| Lethal Dose 50 | 1 | 2003 | 8 | 0.050 |
Why?
|
| Thiourea | 1 | 2002 | 9 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2003 | 171 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2003 | 274 | 0.050 |
Why?
|
| Insecta | 1 | 2023 | 49 | 0.050 |
Why?
|
| Injections, Intraventricular | 1 | 2002 | 19 | 0.050 |
Why?
|
| Albumins | 1 | 2002 | 129 | 0.050 |
Why?
|
| Environment | 1 | 2004 | 225 | 0.050 |
Why?
|
| Sciuridae | 1 | 2002 | 18 | 0.050 |
Why?
|
| Shock, Septic | 1 | 2003 | 105 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2005 | 469 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 469 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2002 | 216 | 0.050 |
Why?
|
| Photic Stimulation | 2 | 2006 | 502 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 754 | 0.050 |
Why?
|
| Thyroid Gland | 1 | 2002 | 280 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2003 | 232 | 0.050 |
Why?
|
| Attention | 1 | 2005 | 395 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2002 | 693 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2000 | 416 | 0.040 |
Why?
|
| Education | 1 | 2020 | 58 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2001 | 996 | 0.040 |
Why?
|
| Macrophages | 1 | 2003 | 578 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1928 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 699 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2003 | 1498 | 0.040 |
Why?
|
| Molecular Sequence Annotation | 1 | 2019 | 71 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 86 | 0.040 |
Why?
|
| Acclimatization | 1 | 2019 | 76 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2019 | 160 | 0.040 |
Why?
|
| Propranolol | 1 | 1998 | 44 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2019 | 102 | 0.040 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2019 | 160 | 0.040 |
Why?
|
| United States | 2 | 2022 | 7050 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1998 | 105 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2001 | 2884 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 961 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 2763 | 0.030 |
Why?
|
| Computational Biology | 1 | 2019 | 550 | 0.030 |
Why?
|
| Postpartum Period | 1 | 1996 | 148 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 1090 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2020 | 1529 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2019 | 851 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3024 | 0.020 |
Why?
|
| Liver | 1 | 2015 | 1208 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2011 | 357 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2011 | 466 | 0.020 |
Why?
|
| Obesity | 1 | 2015 | 971 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 1076 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2006 | 91 | 0.020 |
Why?
|
| Immobilization | 1 | 2004 | 21 | 0.010 |
Why?
|
| Preoptic Area | 1 | 2003 | 6 | 0.010 |
Why?
|
| Oxytocin | 1 | 2004 | 73 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2003 | 25 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 99 | 0.010 |
Why?
|
| Restraint, Physical | 1 | 2003 | 28 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2003 | 169 | 0.010 |
Why?
|
| Wounds, Penetrating | 1 | 2003 | 56 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 432 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 3240 | 0.010 |
Why?
|